CI NYSE Week ended 24 Jul 2026

Weekly Investor Report

Cigna Corp · Healthcare · Healthcare Plans

Open interactive chart View report data Download investor PDF
Latest close 289.6 USD
2.9% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 3.8% above the Trend Line and sits at 72.3% of its 52-week range. The latest completed week returned 2.9%, after a 2.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. Options positioning is volatility with 55/100 conviction, while the latest news-sentiment score is 59/100. Near-term considerations: volume confirmation is below normal; earnings are due in 0d.

Setup score 52 out of 100
Latest Close 289.6 USD 24 Jul 2026
1W Return 2.9% latest completed week
4W Return 2.4% short-term follow-through
12W Return 2.9% quarterly tape
Trend Breadth 23.1% 12 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 12-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.9% Latest completed week; four-week move 2.4%. Indicator stack 54/62 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 55/100 conviction; expected move 7.0%. News sentiment 59/100 43 relevant articles in the latest sentiment read. Event risk 0d Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.8% above the Trend Line and sits at 72.3% of its 52-week range. The latest completed week returned 2.9%, after a 2.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6412-week average 0.41

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.64Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.4% over four weeks, 2.9% over 12 weeks, and -0.2% over one year. The current trend has remained active for 12 consecutive weeks.

Performance by holding period

1W2.9%
4W2.4%
12W2.9%
26W4.9%
52W-0.2%
Active trend streak12 weeks
Active weeks in one year12
Trend breadth23.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.79Latest activity-pressure read.
Pressure change-24.3%Four-week change in activity pressure.
Leadership-4.16Latest relative-leadership reading.
RS change38.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength66/100Blend of value, momentum, and quality. Underlying universe rank 35; rank 1 is best.
Value90/100Relative valuation strength. Underlying universe rank 11; rank 1 is best.
Quality22/100Profitability and accounting quality. Underlying universe rank 79; rank 1 is best.
Momentum27/100Medium-term price momentum. Underlying universe rank 74; rank 1 is best.
Growth28/100Revenue and earnings growth. Underlying universe rank 73; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
12.2x
Price divided by trailing earnings.
Price / sales
0.3x
Market value relative to trailing revenue.
EV / EBITDA
8.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
9.3%
Gross profit retained from each unit of revenue.
Operating margin
3.5%
Operating profit retained from revenue.
Free-cash-flow margin
3.6%
Free cash flow generated from revenue.
Return on invested capital
11.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
8.8%
Latest one-year revenue growth.
EPS growth
24.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
12.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.1%
Cash dividends relative to market value.
Buyback yield
2.5%
Net share repurchases relative to market value.
Shareholder yield
4.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CI shows volatility options pressure with a 55/100 conviction score, put-call volume ratio of 0.22, expected move of 7.0%, and Sharemaestro trend signal active.

Conviction55/100
Expected move7.0%
Put/call volume0.22
Pressure71
Speculation41
Volatility84
Trend agreement31
Open options detail
Insider activity6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment59/100

Weighted news tone is neutral across 43 relevant articles.

21 positive · 21 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings0dNext report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
Options expected move7.0%Nearest-chain priced movement where available.
52-week drawdown-6.7%Distance below the 52-week high.
13-week volatility3.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+6.5%Week of 6 Feb.
Worst week-6.3%Week of 19 Jun.
Latest week+2.9%Week of 24 Jul.

Shape of recent returns

Strong gains2
Modest gains12
Flat weeks0
Modest losses9
Sharp losses3
Recent vol3.1%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape52/100

Trend, activity pressure, participation, and risk combine to a 52/100 tape read.

 Indicator analysis66/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.64; No reversal markers Factors51/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 20 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options45/100

CI shows volatility options pressure with a 55/100 conviction score, put-call volume ratio of 0.22, expected move of 7.0%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 7.0% Sentiment59/100

Weighted news tone is neutral across 43 relevant articles.

Will Declining Medical Customers Affect Cigna's Q2 Earnings? Insiders6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

 Earnings0d

Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026289.6 USD2.9%279.0 USD296.9 USD0.79-4.166.6MOn
17 Jul 2026281.4 USD-4.1%278.5 USD296.8 USD1.00-7.6910.4MOn
10 Jul 2026293.5 USD2.0%278.1 USD296.8 USD0.95-5.626.0MOn
3 Jul 2026287.8 USD1.8%277.3 USD296.6 USD1.02-6.597.2MOn
26 Jun 2026282.8 USD1.3%276.5 USD296.4 USD1.04-6.7410.1MOn
19 Jun 2026279.3 USD-6.3%276.2 USD296.3 USD0.80-10.665.7MOn
12 Jun 2026298.0 USD2.9%276.0 USD296.2 USD0.77-4.437.1MOn
5 Jun 2026289.5 USD4.9%274.9 USD295.9 USD0.62-7.178.0MOn
29 May 2026275.9 USD-3.1%273.9 USD295.7 USD0.53-14.237.7MOn
22 May 2026284.7 USD0.3%272.7 USD295.4 USD0.56-10.876.5MOn
15 May 2026283.7 USD-1.0%273.1 USD295.1 USD0.48-11.029.8MOn
8 May 2026286.5 USD1.8%273.5 USD294.8 USD0.32-10.558.9MOn
1 May 2026281.3 USD2.6%273.8 USD294.5 USD0.02-10.859.3MOff
24 Apr 2026274.1 USD-1.1%274.6 USD294.3 USD-0.21-13.057.9MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.